Valuation: Arcadia Biosciences, Inc.

Market Cap 380K 341K 313K 284K 531K 36.12M 541K 3.74M 1.5M 19M 1.43M 1.4M 59.92M P/E 2024
-1.15x
P/E 2025 -1.16x
Enterprise Value -4.18M -3.75M -3.45M -3.12M -5.84M -397M -5.95M -41.09M -16.49M -209M -15.7M -15.36M -659M EV / Sales 2024
0.79x
EV / Sales 2025 -0.38x
Free-Float
84.13%
Yield 2024 *
-
Yield 2025 -
1 day-7.39%
1 week-2.29%
1 month-43.61%
3 months-74.74%
6 months-84.96%
Current year-92.03%
1 week 0.13
Extreme 0.132
0.18
1 month 0.11
Extreme 0.111
0.31
Current year 0.11
Extreme 0.111
2.75
1 year 0.11
Extreme 0.111
4.18
3 years 0.11
Extreme 0.111
10.31
5 years 0.11
Extreme 0.111
106.4
10 years 0.11
Extreme 0.111
2,662.4
Manager TitleAgeSince
Chief Executive Officer 50 2024-07-04
Director TitleAgeSince
Chairman 57 2017-11-21
Director/Board Member 76 2017-06-12
Director/Board Member 58 2017-08-09
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26 Free

Director

10,000 0.4151%
9/10/26 Free

Chairman

23,000 0.9547%
9/10/26 Free

Director

10,000 0.4151%
Change 5-day change 1-year change 3-year change Capi.($)
-7.39%-2.29%-95.77%-95.39% 380K
+2.28%+1.19%+10.17%-13.62% 264B
+3.85%+1.79%+13.02%-1.92% 82.2B
+1.77%+5.27%-14.55%+16.69% 47.06B
-.--%+0.73%+18.04%+547.12% 45.83B
+0.93%-4.03%+27.06%+7.46% 37.07B
+3.33%-2.38%-2.37%-11.60% 33.28B
-0.39%+1.07%+17.04%+86.79% 31.02B
+0.96%+0.96%-8.53%-7.41% 30B
+1.84%-1.85%-1.58%-22.63% 28.86B
Average +0.72%-0.30%-3.75%+50.55% 59.98B
Weighted average by Cap. +2.03%+0.63%+8.43%+39.69%

Financials

2024 2025
Net sales 5.04M 4.52M 4.16M 3.77M 7.04M 479M 7.17M 49.56M 19.9M 252M 18.93M 18.53M 795M 4.86M 4.35M 4M 3.63M 6.78M 461M 6.91M 47.73M 19.16M 243M 18.23M 17.84M 765M
Net income -7.04M -6.3M -5.8M -5.25M -9.82M -668M -10M -69.14M -27.76M -352M -26.41M -25.85M -1.11B -2.34M -2.09M -1.93M -1.75M -3.26M -222M -3.32M -22.98M -9.22M -117M -8.78M -8.59M -368M
Net Debt -4.09M -3.66M -3.37M -3.05M -5.7M -388M -5.81M -40.15M -16.12M -204M -15.34M -15.01M -644M -4.56M -4.09M -3.76M -3.41M -6.37M -433M -6.49M -44.83M -18M -228M -17.12M -16.76M -719M
Projected Income Statement - Annual - Arcadia Biosciences, Inc.
Logo Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Employees
8
Date Price Change Volume
26-10-30 US$0.1579 -7.39% 847,420
26-10-29 US$0.1705 +7.84% 4,028,523
26-10-28 US$0.1581 -1.06% 69,733
26-10-27 US$0.1598 +5.27% 80,186
26-10-26 US$0.1518 -6.06% 64,542

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Arcadia Biosciences, Inc.
  1. Stock Market
  2. Stocks
  3. RKDA Stock